ad image

Time to Market

1 / 1
Revolutionizing xRNA Production: The Economic Case for Continuous Manufacturing
xRNA

Revolutionizing xRNA Production: The Economic Case for Continuous Manufacturing

Aaron B. Cowley, Ph.D.

ReciBioPharm

PAO-02-25-CL-11Feb 13, 2025
What strategies are being employed to accelerate product development and commercialization without compromising quality?
Accelerating Product Development

What strategies are being employed to accelerate product development and commercialization without compromising quality?

Pharma's Almanac

PAO-03-24-CL-02Mar 08, 2024
Preparing for the Next Pandemic: Lessons Learned from COVID-19
COVID-19

Preparing for the Next Pandemic: Lessons Learned from COVID-19

Sheila Rocchio

eClinical Solutions

PAO-06-21-CL-01Jun 01, 2021
Reducing Fill-Finish Wait Times
Fill-Finish

Reducing Fill-Finish Wait Times

Brian R. Berquist, Ph.D.

iBio, Inc.

PAO-NI-0719-CL-003Jul 25, 2019
Risk Minimization with an Integrated Global Network
Global Network

Risk Minimization with an Integrated Global Network

Servier

PAP-Q4-18-CL-005Oct 26, 2018
Reducing Time to Market with Targeted Regulatory Affairs Support
Regulatory

Reducing Time to Market with Targeted Regulatory Affairs Support

Maryse Phan

Servier

PAO-06-18-CL-003Jun 20, 2018
1 / 1